Patheon signs strategic alliance agreement with Kemwell
Expanding Capabilities to India
The alliance allows Patheon and Kemwell to refer and market each others' services to clients to better meet their respective client's requirements. The alliance is effective immediately and full promotion by Patheon's business development units is expected by mid-year.
"This alliance gives us more flexibility in our service offering. With Kemwell's GMP facility and expertise, we can offer our clients low volume, low cost solutions in solid, semi-solid and liquid dosage form manufacturing, and a full range of formulation and CMC-related development services from a new base in India," said Wes Wheeler, Chief Executive Officer and President of Patheon Inc.
Most read news
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.